ArticleInternational journal of heart failure2026
Ischemic Evaluation and Long-Term Mortality in New-Onset Heart Failure Across Various Age-Groups.
Article in International journal of heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Reflex to Reason: Does New-Onset Heart Failure Warrant a Routine Ischemic Evaluation?International journal of heart failure · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: The prognostic significance of ischemic evaluation in patients with new-onset heart failure is not well understood and may differ according to age and sex. In a real-world cohort, we analyzed the long-term mortality risk after undergoing an ischemic evaluation. Methods: All new-diagnosed heart failure patients 2008-2018 without prior ischemic evaluation, known coronary artery disease, or acute myocardial infarction were identified from the Danish National patient registry. The association of an ischemic evaluation within 90 days of heart failure diagnosis with long-term mortality was analyzed by inverse probability weighted Cox regression models. Results: A total of 61,475 patients were included (mean age 73.3±13.9 years, 46% women), of which 12,503 (20%) underwent an ischemic evaluation. During a mean follow-up of 4.6 years, 37% of patients died, corresponding to a mortality rate of 8.0 (7.9-8.1) per 100 person-years. The multivariable-adjusted hazard ratio of death was 0.92 (95% confidence interval, 0.90-0.95) for patients who underwent ischemic evaluation, compared with patients who did not. An ischemic evaluation was associated with a lower hazard ratio in males than females: 0.87 (0.84-0.90) vs. 0.98 (0.94-1.02), and in middle-aged vs. older or younger individuals: 0.91 (0.75-1.12) in patients ≤50 years, 0.82 (0.72-0.93) in 51-60 years, 0.83 (0.79-0.87) in 61-75 years, 0.93 (0.88-0.97) in >75-85 years, and 1.02 (0.97-1.07) in >85 years, respectively. Conclusions: Obtaining an ischemic evaluation was associated with marginal to no improvement in long-term mortality for many new-diagnosed heart failure patients, including the very elderly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.